Oral Fluid–Based Biomarkers of Alveolar Bone Loss in Periodontitis
dc.contributor.author | Kinney, Janet S. | en_US |
dc.contributor.author | Ramseier, Christoph A. | en_US |
dc.contributor.author | Giannobile, William V. | en_US |
dc.date.accessioned | 2010-06-01T20:07:22Z | |
dc.date.available | 2010-06-01T20:07:22Z | |
dc.date.issued | 2007-03 | en_US |
dc.identifier.citation | KINNEY, JANET S.; RAMSEIER, CHRISTOPH A.; GIANNOBILE, WILLIAM V. (2007). "Oral Fluid–Based Biomarkers of Alveolar Bone Loss in Periodontitis." Annals of the New York Academy of Sciences 1098(1 Oral-Based Diagnostics ): 230-251. <http://hdl.handle.net/2027.42/73247> | en_US |
dc.identifier.issn | 0077-8923 | en_US |
dc.identifier.issn | 1749-6632 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/73247 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17435132&dopt=citation | en_US |
dc.description.abstract | Periodontal disease is a bacteria-induced chronic inflammatory disease affecting the soft and hard supporting structures encompassing the teeth. When left untreated, the ultimate outcome is alveolar bone loss and exfoliation of the involved teeth. Traditional periodontal diagnostic methods include assessment of clinical parameters and radiographs. Though efficient, these conventional techniques are inherently limited in that only a historical perspective, not current appraisal, of disease status can be determined. Advances in the use of oral fluids as possible biological samples for objective measures of current disease state, treatment monitoring, and prognostic indicators have boosted saliva and other oral-based fluids to the forefront of technology. Oral fluids contain locally and systemically derived mediators of periodontal disease, including microbial, host-response, and bone-specific resorptive markers. Although most biomarkers in oral fluids represent inflammatory mediators, several specific collagen degradation and bone turnover-related molecules have emerged as possible measures of periodontal disease activity. Pyridinoline cross-linked carboxyterminal telopeptide (ICTP), for example, has been highly correlated with clinical features of the disease and decreases in response to intervention therapies, and has been shown to possess predictive properties for possible future disease activity. One foreseeable benefit of an oral fluid–based periodontal diagnostic would be identification of highly susceptible individuals prior to overt disease. Timely detection and diagnosis of disease may significantly affect the clinical management of periodontal patients by offering earlier, less invasive, and more cost-effective treatment therapies. | en_US |
dc.format.extent | 156685 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Inc | en_US |
dc.rights | 2007 New York Academy of Sciences | en_US |
dc.subject.other | Periodontal Disease | en_US |
dc.subject.other | Oral Fluids | en_US |
dc.subject.other | Saliva | en_US |
dc.subject.other | Disease Progression | en_US |
dc.subject.other | Diagnosis | en_US |
dc.subject.other | Bone Resorption | en_US |
dc.title | Oral Fluid–Based Biomarkers of Alveolar Bone Loss in Periodontitis | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Science (General) | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Periodontics and Oral Medicine and Michigan Center for Oral Health Research, University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Department of Biomedical Engineering, College of Engineering, University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.identifier.pmid | 17435132 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/73247/1/annals.1384.028.pdf | |
dc.identifier.doi | 10.1196/annals.1384.028 | en_US |
dc.identifier.source | Annals of the New York Academy of Sciences | en_US |
dc.identifier.citedreference | Armitage, G.C. 1999. Development of a classification system for periodontal diseases and conditions. Ann. Periodontol. 4: 1 – 6. | en_US |
dc.identifier.citedreference | Socransky, S.S. & A.D. Haffajee. 1992. The bacterial etiology of destructive periodontal disease: current concepts. J. Periodontol. 63 ( 4 Suppl ): 322 – 331. | en_US |
dc.identifier.citedreference | Genco, R.J. 1992. Host responses in periodontal diseases: current concepts. J. Periodontol. 63 ( 4 Suppl ): 338 – 355. | en_US |
dc.identifier.citedreference | Page, R.C. & K.S. Kornman. 1997. The pathogenesis of human periodontitis: an introduction. Periodontol. 2000 14: 9 – 11. | en_US |
dc.identifier.citedreference | Offenbacher, S. 1996. Periodontal diseases: pathogenesis. Ann. Periodontol. 1: 821 – 878. | en_US |
dc.identifier.citedreference | Albandar, J.M. 1990. A 6-year study on the pattern of periodontal disease progression. J. Clin. Periodontol. 17 ( 7 Pt 1 ): 467 – 471. | en_US |
dc.identifier.citedreference | Albandar, J.M. & D.K. Abbas. 1986. Radiographic quantification of alveolar bone level changes. Comparison of 3 currently used methods. J. Clin. Periodontol. 13: 810 – 813. | en_US |
dc.identifier.citedreference | Socransky, S.S., A.D. Haffajee, J.M. Goodson & J. Lindhe. 1984. New concepts of destructive periodontal disease. J. Clin. Periodontol. 11: 21 – 32. | en_US |
dc.identifier.citedreference | Albandar, J.M. 2002. Periodontal diseases in North America. Periodontol 2000. 29: 31 – 69. | en_US |
dc.identifier.citedreference | Albandar, J.M., J.A. Brunelle & A. Kingman. 1999. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988–1994. J. Periodontol. 70: 13 – 29. | en_US |
dc.identifier.citedreference | Socransky, S.S. & A.D. Haffajee. 2002. Dental biofilms: difficult therapeutic targets. Periodontol. 2000. 28: 12 – 55. | en_US |
dc.identifier.citedreference | Zambon, J.J. 1996. Periodontal diseases: microbial factors. Ann. Periodontol. 1: 879 – 925. | en_US |
dc.identifier.citedreference | Socransky, S.S., A.D. Haffajee, M.A. Cugini, et al. 1998. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25: 134 – 144. | en_US |
dc.identifier.citedreference | Loesche, W.J., D.E. Lopatin, J. Giordano, et al. 1992. Comparison of the benzoyl-DL-arginine-naphthylamide (BANA) test, DNA probes, and immunological reagents for ability to detect anaerobic periodontal infections due to Porphyromonas gingivalis, Treponema denticola, and Bacteroides forsythus. J. Clin. Microbiol. 30: 427 – 433. | en_US |
dc.identifier.citedreference | Loesche, W.J., C.E. Kazor & G.W. Taylor. 1997. The optimization of the BANA test as a screening instrument for gingivitis among subjects seeking dental treatment. J. Clin. Periodontol. 24: 718 – 726. | en_US |
dc.identifier.citedreference | Listgarten, M.A. 1976. Structure of surface coatings on teeth. A review. J. Periodontol. 47: 139 – 147. | en_US |
dc.identifier.citedreference | Listgarten, M.A. & P.M. Loomer. 2003. Microbial identification in the management of periodontal diseases. A systematic review. Ann. Periodontol. 8: 182 – 192. | en_US |
dc.identifier.citedreference | Armitage, G.C. 1996. Periodontal diseases: diagnosis. Ann. Periodontol. 1: 37 – 215. | en_US |
dc.identifier.citedreference | Armitage, G.C. 2004. The complete periodontal examination. Periodontol. 2000 34: 22 – 33. | en_US |
dc.identifier.citedreference | Lamster, I.B. & J.T. Grbic. 1995. Diagnosis of periodontal disease based on analysis of the host response. Periodontol. 2000. 7: 83 – 99. | en_US |
dc.identifier.citedreference | Haffajee, A.D., S.S. Socransky & J.M. Goodson. 1983. Clinical parameters as predictors of destructive periodontal disease activity. J. Clin. Periodontol. 10: 257 – 265. | en_US |
dc.identifier.citedreference | Goodson, J.M. 1992. Diagnosis of periodontitis by physical measurement: interpretation from episodic disease hypothesis. J. Periodontol. 63 ( 4 Suppl ): 373 – 382. | en_US |
dc.identifier.citedreference | Haffajee, A.D., S.S. Socransky, J. Lindhe, et al. Clinical risk indicators for periodontal attachment loss. J. Clin. Periodontol. 18: 117 – 125. | en_US |
dc.identifier.citedreference | Streckfus, C.F. & L.R. Bigler. 2002. Saliva as a diagnostic fluid. Oral Dis. 8: 69 – 76. | en_US |
dc.identifier.citedreference | Mandel, I.D. 1990. The diagnostic uses of saliva. J. Oral Pathol. Med. 19: 119 – 125. | en_US |
dc.identifier.citedreference | Mandel, I.D. 1993. Salivary diagnosis: promises, promises. Ann. N. Y. Acad. Sci. 694: 1 – 10. | en_US |
dc.identifier.citedreference | Mandel, I.D. 1993. A contemporary view of salivary research. Crit. Rev. Oral Biol. Med. 4: 599 – 604. | en_US |
dc.identifier.citedreference | Mandel, I.D. 1993. Salivary diagnosis: more than a lick and a promise. J. Am. Dent. Assoc. 124: 85 – 87. | en_US |
dc.identifier.citedreference | 29. Biomarkers Definitions Working Group. 2001. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69: 89 – 95. | en_US |
dc.identifier.citedreference | Ferguson, D.B. 1987. Current diagnostic uses of saliva. J. Dent. Res. 66: 420 – 424. | en_US |
dc.identifier.citedreference | Kaufman, E. & I.B. Lamster. 2000. Analysis of saliva for periodontal diagnosis–a review. J. Clin. Periodontol. 27: 453 – 465. | en_US |
dc.identifier.citedreference | Nakamura, M. & J. Slots. 1983. Salivary enzymes. Origin and relationship to periodontal disease. J. Periodontal Res. 18: 559 – 569. | en_US |
dc.identifier.citedreference | Ozmeric, N. 2004. Advances in periodontal disease markers. Clin. Chim. Acta. 343: 1 – 16. | en_US |
dc.identifier.citedreference | Nakashima, K., C. Giannopoulou, E. Andersen, et al. 1996. A longitudinal study of various crevicular fluid components as markers of periodontal disease activity. J. Clin. Periodontol. 23: 832 – 838. | en_US |
dc.identifier.citedreference | Singh, A.K., A.E. Herr, A.V. Hatch, et al. 2006. Integrated microfluidic platform for oral diagnostics (IMPOD) [abstract]. New York Academy of Sciences: Oral-Based Diagnostics—A New York Academy of Sciences Meeting. | en_US |
dc.identifier.citedreference | Ramseier, C.A., J.S. Kinney, A.E. Herr, et al. 2006. Salivary diagnostics for inflammatory periodontal diseases [abstract]. New York Academy of Sciences: Oral-Based Diagnostics—A New York Academy of Sciences Meeting. | en_US |
dc.identifier.citedreference | Kornman, K.S., R.C. Page & M.S. Tonetti. 1997. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol. 2000. 14: 33 – 53. | en_US |
dc.identifier.citedreference | Mantyla, P., M. Stenman, D.F. Kinane, et al. 2003. Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis. J. Periodontal Res. 38: 436 – 439. | en_US |
dc.identifier.citedreference | Taba, M., Jr, J. Kinney, A.S. Kim & W.V. Giannobile. 2005. Diagnostic biomarkers for oral and periodontal diseases. Dent. Clin. North Am. 49: 551–571, vi. | en_US |
dc.identifier.citedreference | Cimasoni, G. 1983. Crevicular fluid updated. Monogr. Oral Sci. 12: III–VII, 1–152. | en_US |
dc.identifier.citedreference | Loos, B.G. & S. Tjoa. 2005. Host-derived diagnostic markers for periodontitis: do they exist in gingival crevice fluid? Periodontol 2000. 39: 53 – 72. | en_US |
dc.identifier.citedreference | Golub, L.M., K. Siegel, N.S. Ramamurthy & I.D. Mandel. 1976. Some characteristics of collagenase activity in gingival crevicular fluid and its relationship to gingival diseases in humans. J. Dent. Res. 55: 1049 – 1057. | en_US |
dc.identifier.citedreference | Golub, L.M. & I. Kleinberg. 1976. Gingival crevicular fluid: a new diagnostic aid in managing the periodontal patient. Oral Sci. Rev. 8: 49 – 61. | en_US |
dc.identifier.citedreference | Robertson, P.B., H.E. Grupe, Jr, R.E. Taylor, et al. 1973. The effect of collagenase-inhibitor complexes on collagenolytic activity of normal and inflamed gingival tissue. J. Oral Pathol. 2: 28 – 32. | en_US |
dc.identifier.citedreference | Kowashi, Y., F. Jaccard & G. Cimasoni. 1979. Increase of free collagenase and neutral protease activities in the gingival crevice during experimental gingivitis in man. Arch. Oral Biol. 24: 645 – 650. | en_US |
dc.identifier.citedreference | Villela, B., R.B. Cogen, A.A. Bartolucci & H. Birkedal-Hansen. 1987. Collagenolytic activity in crevicular fluid from patients with chronic adult periodontitis, localized juvenile periodontitis and gingivitis, and from healthy control subjects. J. Periodontal. Res. 22: 381 – 389. | en_US |
dc.identifier.citedreference | Airila-Mansson, S., B. Soder, K. Kari & J.H. Meurman. 2006. Influence of combinations of bacteria on the levels of prostaglandin E2, interleukin-1beta, and granulocyte elastase in gingival crevicular fluid and on the severity of periodontal disease. J. Periodontol. 77: 1025 – 1031. | en_US |
dc.identifier.citedreference | Ikarashi, F., K. Yamazaki, K. Hara & H. Nohara. 1990. Production of prostaglandin E2 by polymorphonuclear neutrophils isolated from gingival crevicular fluid and peripheral blood of dogs in periodontal health and disease. Nippon Shishubyo Gakkai Kaishi 32: 121 – 128. | en_US |
dc.identifier.citedreference | Weyna, E. 1985. Comparative evaluation of histological studies of the gingiva and levels of prostaglandin-like substances in cases of deep inflammatory periodontal disease. Czas. Stomatol. 38: 53 – 56. | en_US |
dc.identifier.citedreference | Weyna, E. 1983. Levels of prostaglandin-like substances in the gingiva of subjects with healthy periodontium or in patients with inflammatory periodontal disease as determined by biological methods. Czas. Stomatol. 36: 289 – 293. | en_US |
dc.identifier.citedreference | Loning, T., H.K. Albers, B.P. Lisboa, et al. 1980. Prostaglandin E and the local immune response in chronic periodontal disease. Immunohistochemical and radioimmunological observations. J. Periodontal. Res. 15: 525 – 535. | en_US |
dc.identifier.citedreference | Goodson, J.M., F.E. Dewhirst & A. Brunetti. 1974. Prostaglandin E2 levels and human periodontal disease. Prostaglandins 6: 81 – 85. | en_US |
dc.identifier.citedreference | Nakashima, K., N. Roehrich, G. Cimasoni. 1994. Osteocalcin, prostaglandin E2 and alkaline phosphatase in gingival crevicular fluid: their relations to periodontal status. J. Clin. Periodontol. 21: 327 – 333. | en_US |
dc.identifier.citedreference | Offenbacher, S., B.M. Odle, R.C. Gray & T.E. Van Dyke. 1984. Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adult and juvenile periodontitis patients. J. Periodontal. Res. 19: 1 – 13. | en_US |
dc.identifier.citedreference | Offenbacher, S., B.M. Odle & T.E. Van Dyke. 1986. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J. Periodontal. Res. 21: 101 – 112. | en_US |
dc.identifier.citedreference | Pederson, E.D., S.R. Stanke, S.J. Whitener, et al. 1995. Salivary levels of alpha 2-macroglobulin, alpha 1-antitrypsin, C-reactive protein, cathepsin G and elastase in humans with or without destructive periodontal disease. Arch. Oral Biol. 40: 1151 – 1155. | en_US |
dc.identifier.citedreference | Iijima, K., K. Ando, M. Kishi, et al. 1983. Collagenase activity in human saliva. J. Dent. Res. 62: 709 – 712. | en_US |
dc.identifier.citedreference | Basu, M.K., E.C. Fox & J.F. Becker. 1976. Salivary IgG and IgA before and after periodontal therapy. A preliminary report. J. Periodontal. Res. 11: 226 – 229. | en_US |
dc.identifier.citedreference | Sandholm, L. & E. Gronblad. 1984. Salivary immunoglobulins in patients with juvenile periodontitis and their healthy siblings. J. Periodontol. 55: 9 – 12. | en_US |
dc.identifier.citedreference | Sandholm, L., K. Tolo & I. Olsen. 1987. Salivary IgG, a parameter of periodontal disease activity? High responders to Actinobacillus actinomycetemcomitans Y4 in juvenile and adult periodontitis. J. Clin. Periodontol. 14: 289 – 294. | en_US |
dc.identifier.citedreference | Schenck, K., D. Poppelsdorf, C. Denis & T. Tollefsen. 1993. Levels of salivary IgA antibodies reactive with bacteria from dental plaque are associated with susceptibility to experimental gingivitis. J. Clin. Periodontol. 20: 411 – 417. | en_US |
dc.identifier.citedreference | Ishikawa, I. & G. Cimasoni. 1970. Alkaline phosphatase in human gingival fluid and its relation to periodontitis. Arch. Oral Biol. 15: 1401 – 1404. | en_US |
dc.identifier.citedreference | Gibert, P., P. Tramini, V. Sieso & M.T. Piva. 2003. Alkaline phosphatase isozyme activity in serum from patients with chronic periodontitis. J. Periodontal. Res. 38: 362 – 365. | en_US |
dc.identifier.citedreference | Totan, A., M. Greabu, C. Totan & T. Spinu. 2006. Salivary aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase: possible markers in periodontal diseases? Clin. Chem. Lab. Med. 44: 612 – 615. | en_US |
dc.identifier.citedreference | Todorovic, T., I. Dozic, M. Vicente-Barrero, et al. 2006. Salivary enzymes and periodontal disease. Med. Oral Patol. Oral Cir. Bucal. 11: E115 – E119. | en_US |
dc.identifier.citedreference | McCauley, L.K. & R.M. Nohutcu. 2002. Mediators of periodontal osseous destruction and remodeling: principles and implications for diagnosis and therapy. J. Periodontol. 73: 1377 – 1391. | en_US |
dc.identifier.citedreference | Kennett, C.N., S.W. Cox & B.M. Eley. 1997. Investigations into the cellular contribution to host tissue proteases and inhibitors in gingival crevicular fluid. J. Clin. Periodontol. 24: 424 – 431. | en_US |
dc.identifier.citedreference | Kunimatsu, K., K. Yamamoto, E. Ichimaru, et al. 1990. Cathepsins B, H and L activities in gingival crevicular fluid from chronic adult periodontitis patients and experimental gingivitis subjects. J. Periodontal. Res. 25: 69 – 73. | en_US |
dc.identifier.citedreference | Ichimaru, E., M. Tanoue, M. Tani, et al. 1996. Cathepsin B in gingival crevicular fluid of adult periodontitis patients: identification by immunological and enzymological methods. Inflamm. Res. 45: 277 – 282. | en_US |
dc.identifier.citedreference | Chen, H.Y., S.W. Cox & B.M. Eley. 1998. Cathepsin B, alpha2-macroglobulin and cystatin levels in gingival crevicular fluid from chronic periodontitis patients. J. Clin. Periodontol. 25: 34 – 41. | en_US |
dc.identifier.citedreference | Cox, S.W. & B.M. Eley. 1992. Cathepsin B/L-, elastase-, tryptase-, trypsin- and dipeptidyl peptidase IV-like activities in gingival crevicular fluid. A comparison of levels before and after basic periodontal treatment of chronic periodontitis patients. J. Clin. Periodontol. 19: 333 – 339. | en_US |
dc.identifier.citedreference | Eley, B.M. & S.W. Cox. 1996. The relationship between gingival crevicular fluid cathepsin B activity and periodontal attachment loss in chronic periodontitis patients: a 2-year longitudinal study. J. Periodontal. Res. 31: 381 – 392. | en_US |
dc.identifier.citedreference | Woessner, J.F., Jr. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145 – 2154. | en_US |
dc.identifier.citedreference | Birkedal-Hansen, H. 1993. Role of matrix metalloproteinases in human periodontal diseases. J. Periodontol. 64 ( 5 Suppl ): 474 – 484. | en_US |
dc.identifier.citedreference | Salo, T., M. Makela, M. Kylmaniemi, et al. 1994. Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab. Invest. 70: 176 – 182. | en_US |
dc.identifier.citedreference | Llano, E., A.M. Pendas, V. Knauper, et al. 1997. Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 36: 15101 – 15108. | en_US |
dc.identifier.citedreference | Pirila, E., N. Ramamurthy, P. Maisi, et al. 2001. Wound healing in ovariectomized rats: effects of chemically modified tetracycline (CMT-8) and estrogen on matrix metalloproteinases -8, -13 and type I collagen expression. Curr. Med. Chem. 8: 281 – 294. | en_US |
dc.identifier.citedreference | Chubinskaya, S., K. Huch, K. Mikecz, et al. 1996. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints. Lab. Invest. 74: 232 – 240. | en_US |
dc.identifier.citedreference | Golub, L.M., H.M. Lee, R.A. Greenwald, et al. 1997. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm. Res. 46: 310 – 319. | en_US |
dc.identifier.citedreference | Lee, W., S. Aitken, G. Kulkarni, et al. 1991. Collagenase activity in recurrent periodontitis: relationship to disease progression and doxycycline therapy. J. Periodontal. Res. 26: 479 – 485. | en_US |
dc.identifier.citedreference | Lee, W., S. Aitken, J. Sodek & C.A. McCulloch. 1995. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J. Periodontal. Res. 30: 23 – 33. | en_US |
dc.identifier.citedreference | Nomura, T., A. Ishii, Y. Oishi, et al. 1998. Tissue inhibitors of metalloproteinases level and collagenase activity in gingival crevicular fluid: the relevance to periodontal diseases. Oral Dis. 4: 231 – 240. | en_US |
dc.identifier.citedreference | Mancini, S., R. Romanelli, C.A. Laschinger, et al. 1999. Assessment of a novel screening test for neutrophil collagenase activity in the diagnosis of periodontal diseases. J. Periodontol. 70: 1292 – 1302. | en_US |
dc.identifier.citedreference | Golub, L.M., S. Ciancio, N.S. Ramamamurthy, et al. 1990. Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J. Periodontal. Res. 25: 321 – 330. | en_US |
dc.identifier.citedreference | Golub, L.M., M. Wolff, S. Roberts, et al. 1994. Treating periodontal diseases by blocking tissue-destructive enzymes. J. Am. Dent. Assoc. 125: 163 – 169; discussion 169–171. | en_US |
dc.identifier.citedreference | Teronen, O., Y.T. Konttinen, C. Lindqvist, et al. 1997. Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate. J. Dent. Res. 76: 1529 – 1537. | en_US |
dc.identifier.citedreference | Ma, J., U. Kitti, O. Teronen, et al. 2000. Collagenases in different categories of peri-implant vertical bone loss. J. Dent. Res. 79: 1870 – 1873. | en_US |
dc.identifier.citedreference | Kivela-Rajamaki, M.J., O.P. Teronen, P. Maisi, et al. 2003. Laminin-5 gamma2-chain and collagenase-2 (MMP-8) in human peri-implant sulcular fluid. Clin. Oral Implants. Res. 14: 158 – 165. | en_US |
dc.identifier.citedreference | Kivela-Rajamaki, M., P. Maisi, R. Srinivas, et al. 2003. Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid. J. Periodontal. Res. 38: 583 – 590. | en_US |
dc.identifier.citedreference | Teng, Y.T., J. Sodek & C.A. McCulloch. 1992. Gingival crevicular fluid gelatinase and its relationship to periodontal disease in human subjects. J. Periodontal. Res. 27: 544 – 552. | en_US |
dc.identifier.citedreference | Johansson, N. & V.M. Kahari. 2000. Matrix metalloproteinases in squamous cell carcinoma. Histol. Histopathol. 15: 225 – 237. | en_US |
dc.identifier.citedreference | Konttinen, Y.T., T. Salo, R. Hanemaaijer, et al. 1999. Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: localization in the pannus-hard tissue junction and inhibition by alendronate. Matrix Biol. 18: 401 – 412. | en_US |
dc.identifier.citedreference | Tervahartiala, T., E. Pirila, A. Ceponis, et al. 2000. The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis. J. Dent. Res. 79: 1969 – 1977. | en_US |
dc.identifier.citedreference | Kiili, M., S.W. Cox, H.Y. Chen, et al. 2002. Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J. Clin. Periodontol. 29: 224 – 232. | en_US |
dc.identifier.citedreference | Uitto, V.J., K. Airola, M. Vaalamo, et al. 1998. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am. J. Pathol. 152: 1489 – 1499. | en_US |
dc.identifier.citedreference | Fagerhol, M.K. 2000. Calprotectin, a faecal marker of organic gastrointestinal abnormality. Lancet. 356: 1783 – 1784. | en_US |
dc.identifier.citedreference | Poullis, A., R. Foster, M.A. Mendall & M.K. Fagerhol. 2003. Emerging role of calprotectin in gastroenterology. J. Gastroenterol. Hepatol. 18: 756 – 762. | en_US |
dc.identifier.citedreference | Kido, J., T. Nakamura, R. Kido, et al. 1999. Calprotectin in gingival crevicular fluid correlates with clinical and biochemical markers of periodontal disease. J. Clin. Periodontol. 26: 653 – 657. | en_US |
dc.identifier.citedreference | Nisapakultorn, K., K.F. Ross & M.C. Herzberg. 2001. Calprotectin expression in vitro by oral epithelial cells confers resistance to infection by Porphyromonas gingivalis. Infect. Immun. 69: 4242 – 4247. | en_US |
dc.identifier.citedreference | Bataille, R., P. Delmas & J. Sany. 1987. Serum bone gla-protein in multiple myeloma. Cancer 59: 329 – 334. | en_US |
dc.identifier.citedreference | Slovik, D.M., C.M. Gundberg, R.M. Neer & J.B. Lian. 1984. Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. J. Clin. Endocrinol. Metab. 59: 228 – 230. | en_US |
dc.identifier.citedreference | Giannobile, W.V., S.E. Lynch, R.G. Denmark, et al. 1995. Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis. A pilot study in beagle dogs. J. Clin. Periodontol. 22: 903 – 910. | en_US |
dc.identifier.citedreference | Kunimatsu, K., S. Mataki, H. Tanaka, et al. 1993. A cross-sectional study on osteocalcin levels in gingival crevicular fluid from periodontal patients. J. Periodontol. 64: 865 – 869. | en_US |
dc.identifier.citedreference | Lee, A.J., T.F. Walsh, S.J. Hodges, A. Rawlinson. 1999. Gingival crevicular fluid osteocalcin in adult periodontitis. J. Clin. Periodontol. 26: 252 – 256. | en_US |
dc.identifier.citedreference | Williams, R.C., D.W. Paquette, S. Offenbacher, et al. 2001. Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial. J. Periodontol. 72: 1535 – 1544. | en_US |
dc.identifier.citedreference | Griffiths, G.S., A.M. Moulson, A. Petrie & I.T. James. 1998. Evaluation of osteocalcin and pyridinium crosslinks of bone collagen as markers of bone turnover in gingival crevicular fluid during different stages of orthodontic treatment. J. Clin. Periodontol. 25: 492 – 498. | en_US |
dc.identifier.citedreference | Giannobile, W.V., K.F. Al-Shammari & D.P. Sarment. 2003. Matrix molecules and growth factors as indicators of periodontal disease activity. Periodontol. 2000 31: 125 – 134. | en_US |
dc.identifier.citedreference | Armitage, G.C., M.K. Jeffcoat, D.E. Chadwick, et al. 1994. Longitudinal evaluation of elastase as a marker for the progression of periodontitis. J. Periodontol. 65: 120 – 128. | en_US |
dc.identifier.citedreference | Oringer, R.J., M.D. Palys, A. Iranmanesh, et al. 1998. C-telopeptide pyridinoline cross-links (ICTP) and periodontal pathogens associated with endosseous oral implants. Clin. Oral Implants. Res. 9: 365 – 373. | en_US |
dc.identifier.citedreference | Palys, M.D., A.D. Haffajee, S.S. Socransky & W.V. Giannobile. 1998. Relationship between C-telopeptide pyridinoline cross-links (ICTP) and putative periodontal pathogens in periodontitis. J. Clin. Periodontol. 25 ( 11 Pt 1 ): 865 – 871. | en_US |
dc.identifier.citedreference | Shibutani, T., Y. Murahashi, E. Tsukada, et al. 1997. Experimentally induced periodontitis in beagle dogs causes rapid increases in osteoclastic resorption of alveolar bone. J. Periodontol. 68: 385 – 391. | en_US |
dc.identifier.citedreference | Talonpoika, J.T. & M.M. Hamalainen. 1994. Type I collagen carboxyterminal telopeptide in human gingival crevicular fluid in different clinical conditions and after periodontal treatment. J. Clin. Periodontol. 21: 320 – 326. | en_US |
dc.identifier.citedreference | Gapski, R., J.L. Barr, D.P. Sarment, et al. 2004. Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair: a proof of concept trial. J. Periodontol. 75: 441 – 452. | en_US |
dc.identifier.citedreference | Perez, L.A., K.F. Al-Shammari, W.V. Giannobile & H.L. Wang. 2002. Treatment of periodontal disease in a patient with Ehlers-Danlos syndrome. A case report and literature review. J. Periodontol. 73: 564 – 570. | en_US |
dc.identifier.citedreference | Oringer, R.J., K.F. Al-Shammari, W.A. Aldredge, et al. 2002. Effect of locally delivered minocycline microspheres on markers of bone resorption. J. Periodontol. 73: 835 – 842. | en_US |
dc.identifier.citedreference | Al-Shammari, K.F., W.V. Giannobile, W.A. Aldredge, et al. 2001. Effect of non-surgical periodontal therapy on C-telopeptide pyridinoline cross-links (ICTP) and interleukin-1 levels. J. Periodontol. 72: 1045 – 1051. | en_US |
dc.identifier.citedreference | Giannobile, W.V. 1999. C-telopeptide pyridinoline cross-links. Sensitive indicators of periodontal tissue destruction. Ann. N. Y. Acad. Sci. 878: 404 – 412. | en_US |
dc.identifier.citedreference | Termine, J.D., H.K. Kleinman, S.W. Whitson, et al. 1981. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26 ( 1 Pt 1 ): 99 – 105. | en_US |
dc.identifier.citedreference | Bowers, M.R., L.W. Fisher, J.D. Termine & M.J. Somerman. 1989. Connective tissue-associated proteins in crevicular fluid: potential markers for periodontal diseases. J. Periodontol. 60: 448 – 451. | en_US |
dc.identifier.citedreference | Oldberg, A., A. Franzen & D. Heinegard. 1986. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl. Acad. Sci. USA 83: 8819 – 8823. | en_US |
dc.identifier.citedreference | Rodan, G.A. 1995. Osteopontin overview. Ann. N. Y. Acad. Sci. 760: 1 – 5. | en_US |
dc.identifier.citedreference | Reinholt, F.P., K. Hultenby, A. Oldberg & D. Heinegard. 1990. Osteopontin—a possible anchor of osteoclasts to bone. Proc. Natl. Acad. Sci. USA 87: 4473 – 4475. | en_US |
dc.identifier.citedreference | Kadono, H., J. Kido, M. Kataoka, et al. 1999. Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect. Immun. 67: 2841 – 2846. | en_US |
dc.identifier.citedreference | Heinegard, D., G. Andersson, F.P. Reinholt. 1995. Roles of osteopontin in bone remodeling. Ann. N. Y. Acad. Sci. 760: 213 – 222. | en_US |
dc.identifier.citedreference | Owen, T.A., M. Aronow, V. Shalhoub, et al. 1990. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol. 143: 420 – 430. | en_US |
dc.identifier.citedreference | Ikeda, T., S. Nomura, A. Yamaguchi, et al. 1992. In situ hybridization of bone matrix proteins in undecalcified adult rat bone sections. J. Histochem. Cytochem. 40: 1079 – 1088. | en_US |
dc.identifier.citedreference | Horton, M.A., M.A. Nesbit & M.H. Helfrich. 1995. Interaction of osteopontin with osteoclast integrins. Ann. N. Y. Acad. Sci. 760: 190 – 200. | en_US |
dc.identifier.citedreference | Kido, J., T. Nakamura, Y. Asahara, et al. 2001. Osteopontin in gingival crevicular fluid. J. Periodontal. Res. 36: 328 – 333. | en_US |
dc.identifier.citedreference | Sharma, C.G. & A.R. Pradeep. 2006. Gingival crevicular fluid osteopontin levels in periodontal health and disease. J. Periodontol. 77: 1674 – 1680. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.